Optopatch: high-throughput all-optical electrophysiology for neural recording The convergence of stem cell, genomic, and advanced imaging technologies provides unprecedented ability to study human neural physiology, in health and disease. Traditionally intractable diseases-schizophrenia, autism, Alzheimer's, ALS and Parkinson's-are being modeled in vitro with stem cell-derived cultures of human neurons. Genome sequencing, and more recently, editing, technologies are helping to disentangle the complex genetic interactions that contribute to the pathophysiology. Yet a key challenge has been to probe neuronal function in stem cell-derived disease models with single-cell resolution, adequate throughput, and over repeated measurements. Due to its low throughput, manual electrophysiology is not compatible with drug screening. Direct visualization of neural activity-conversion of action potentials into flashes of light- would revolutionize our study of neural circuits. The Cohen Lab has developed a genetic construct that enables simultaneous optical stimulation and optical recording of electrical activity in neurons. One protein converts blue ligh into electrical stimuli; a second protein converts neuronal activity into flashes of near infrared fluorescence. Q-State Biosciences aims to develop the technology to take this tool from the lab to the marketplace.
The aim of this proposal is to develop a prototype instrument for simultaneous spatially resolved optical stimulation and imaging (Optopatch) in complex neuronal cultures. This instrument will enable all-optical electrophysiology in samples containing up to 2,000 neurons, with millisecond temporal resolution, micron spatial resolution, and independent stimulation and readout of each cell. The Cohen Lab has a proof-of-principle machine with these capabilities. Many neuroscience, cardiology, stem cell, and pharmaceutical labs would like to use this tool. However, three further advances are needed for the technology to be widely adopted: 1) to create instrumentation which can perform robustly in daily use; 2) to write software to manage and analyze the torrents of high-dimensional data that Optopatch generates; and 3) to develop stimulation analysis protocols that accentuate biologically meaningful features of the neural network, e.g. excitability, synaptic strength, topology, and plasticity.

Public Health Relevance

Optopatch: high-throughput all-optical electrophysiology for neural recording. This proposal is to develop a machine that uses light to stimulate and record from thousands of neurons in parallel. This technology will be useful in studying cell-based models of neuropsychiatric and neurodegenerative diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
5R43NS087714-02
Application #
8821685
Study Section
Special Emphasis Panel (ZRG1-ETTN-C (10))
Program Officer
Ludwig, Kip A
Project Start
2014-04-01
Project End
2016-03-31
Budget Start
2015-04-01
Budget End
2016-03-31
Support Year
2
Fiscal Year
2015
Total Cost
$329,000
Indirect Cost
Name
Q-State Biosciences, Inc.
Department
Type
DUNS #
078880703
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Werley, Christopher A; Brookings, Ted; Upadhyay, Hansini et al. (2017) All-Optical Electrophysiology for Disease Modeling and Pharmacological Characterization of Neurons. Curr Protoc Pharmacol 78:11.20.1-11.20.24